Related Experiment Videos
Management of hepatic encephalopathy
Gerald Kircheis1, Dieter Häussinger
1Clinic for Gastroenterology, Hepatology und Infectiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. Kircheis@med.uni-duesseldorf.de
Journal of Gastroenterology and Hepatology
|December 11, 2002
Summary
Hepatic encephalopathy (HE) is a brain dysfunction linked to cerebral edema. Identifying and treating triggers like ammonia and inflammation is key for HE management.
Area of Science:
- Hepatology
- Neurology
- Gastroenterology
Background:
- Hepatic encephalopathy (HE) is a neurological complication of liver dysfunction.
- It is characterized by cerebral edema and altered glioneural communication.
- Various factors can precipitate or worsen HE episodes.
Purpose of the Study:
- To review the therapeutic approaches for hepatic encephalopathy.
- To identify treatments with proven efficacy based on placebo-controlled trials.
Main Methods:
- Literature review of studies on hepatic encephalopathy treatment.
- Focus on evidence from placebo-controlled trials.
Main Results:
- Several treatments show efficacy in HE, including liver transplantation, protein restriction, vegetable proteins, ornithine-aspartate, oral branched-chain amino acids, and lactulose enemas.
- Oral lactulose efficacy is not supported by placebo-controlled trials.
Conclusions:
- Rigorous identification and treatment of precipitating factors are crucial for HE therapy.
- Specific interventions like transplantation and certain oral/enema treatments have demonstrated efficacy.
- Further research is needed to establish the efficacy of oral lactulose.